Factors promoting success and influencing complications in laser-induced central vein bypass

Ophthalmology

Volumn 119, Issue 12, 2012, Pages 2579-2586

  McAllister, Ian L ^a   Gillies, Mark E ^b   Smithies, Lynne A ^a   Rochtchina, Elena ^c   Harper, Colin A ^d   Daniell, Mark D ^d   Constable, Ian J ^a   Mitchell, Paul ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN;

AGE DISTRIBUTION; AGED; ANALYTICAL PARAMETERS; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FLUORESCEIN TRANSIT TIME; FOLLOW UP; HUMAN; HYPERTENSION; INTERVENTION STUDY; LASER INDUCED CHORIORETINAL VENOUS ANASTOMOSIS; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINA SURGERY; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT OUTCOME; VEIN RUPTURE; VISUAL ACUITY;

AGED; ANASTOMOSIS, SURGICAL; CHOROID; COHORT STUDIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAOCULAR PRESSURE; INTRAOPERATIVE COMPLICATIONS; LASER THERAPY; LASERS, EXCIMER; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETINAL VEIN; RETINAL VEIN OCCLUSION; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84870712219     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.06.047     Document Type: Article

References (32)

1. R. Klein, B.E. Klein, S.E. Moss, S.M. Meuer The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study Trans Am Ophthalmol Soc 98 2000 133 141
2. P. Mitchell, W. Smith, A. Chang Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountain Eye Study Arch Ophthalmol 114 1996 1243 1247
3. S. Rogers, R.L. McIntosh, N. Cheung International Eye Disease Consortium The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia Ophthalmology 117 2010 313 319
4. W.R. Green, C.C. Chan, G.M. Hutchins, J.M. Terry Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases Trans Am Ophthalmol Soc 79 1981 371 442
5. S.S. Hayreh Prevalent misconceptions about acute retinal vascular occlusive disorders Prog Retin Eye Res 24 2005 493 519
6. P.E. Beaumont, H.K. Kang Pattern of vascular nonperfusion in retinal venous occlusions occurring within the optic nerve with and without optic nerve head swelling Arch Ophthalmol 118 2000 1357 1363
7. I.L. McAllister, M.E. Gillies, L.A. Smithies The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion Ophthalmology 117 2010 954 965
8. P.J. Rosenfeld, A.E. Fung, C.A. Puliafito Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion Ophthalmic Surg Lasers Imaging 36 2005 336 339
9. D. Iturralde, R.F. Spaide, C.B. Meyerle Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study Retina 26 2006 279 284
10. R.A. Costa, R. Jorge, D. Calucci Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study Retina 27 2007 141 149
11. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
12. P.A. Campochiaro, D.M. Brown, C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 2011 2041 2049
13. J.S. Heier, P.A. Campochiaro, L. Yau Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial Ophthalmology 119 2012 802 809
14. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5 Arch Ophthalmol 127 2009 1101 1114
15. J.B. Jonas Ophthalmodynamometric assessment of the central retinal vein collapse pressure in eyes with retinal vein stasis or occlusion Graefes Arch Clin Exp Ophthalmol 241 2003 367 370
16. S.S. Hayreh, P.A. Podhajsky, M.B. Zimmerman Natural history of visual outcome in central retinal vein occlusion Ophthalmology 118 2011 119 133
17. Central Vein Occlusion Study Group A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N report Ophthalmology 102 1995 1434 1444
18. Central Vein Occlusion Study Group Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report Ophthalmology 102 1995 1425 1433
19. P.A. Campochiaro, G. Hafiz, R. Channa Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes Ophthalmology 117 2010 2387 2394
20. A. Rivard, J.E. Fabre, M. Silver Age-dependent impairment of angiogenesis Circulation 99 1999 111 120
21. Central Vein Occlusion Study Group Natural history and clinical management of central retinal vein occlusion Arch Ophthalmol 115 1997 486 491
22. R. Funk, J.W. Rohen Comparative morphological studies on blood vessels in eyes of normotensive and spontaneously hypertensive rats Exp Eye Res 40 1985 191 203
23. R. Margolis, R.F. Spaide A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes Am J Ophthalmol 147 2009 811 815
24. D.C. Sane, L. Anton, K.B. Brosnihan Angiogenic growth factors and hypertension Angiogenesis 7 2004 193 201
25. S. Vijayasekaran, D.Y. Yu, I.L. McAllister Optimal conditions required for the creation of an iatrogenic chorioretinal venous anastomosis in the dog using argon green laser photocoagulation Curr Eye Res 14 1995 63 70
26. S. Vijayasekaran, D.Y. Yu, I.L. McAllister Significance of Bruch's membrane in the creation of iatrogenic chorioretinal venous anastomosis Curr Eye Res 13 1994 29 33
27. I.L. McAllister, S. Vijayasekaran, D.Y. Yu, I.J. Constable Chorioretinal venous anastomoses: effect of different laser methods and energy in human eyes without vein occlusion Graefes Arch Clin Exp Ophthalmol 236 1998 174 181
28. J. Pe'er, R. Folberg, A. Itin Vascular endothelial growth factor upregulation in human central retinal vein occlusion Ophthalmology 105 1998 412 416
29. I.L. McAllister, J.P. Douglas, I.J. Constable, D.Y. Yu Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors Am J Ophthalmol 126 1998 219 229
30. D.J. Browning, A.N. Antoszyk Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion Ophthalmology 105 1998 670 677 discussion 677-9
31. C.S. Fong, C. Barry, I.L. McAllister Intravitreal bevacizumab (Avastin) as a treatment of the neovascular complications of laser-induced chorioretinal anastomosis for nonischaemic central retinal vein occlusion Clin Experiment Ophthalmol 37 2009 485 489
32. I. Tsui, A. Kaines, M.A. Havunjian Ischemic index and neovascularization in central retinal vein occlusion Retina 31 2011 105 110